Folate receptor-targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: Can it distinguish vulnerable from stable atherosclerotic plaques?

Molecular Imaging

Volumn 13, Issue 1, 2014, Pages

  Winkel, Leah C J ^a,b   Groen, Harald C ^a,b   Van Thiel, Bibi S ^a,b   Müller, Cristina ^a,b   Van Der Steen, Antonius F W ^a,b   Wentzel, Jolanda J ^a,b   De Jong, Marion ^a,b   Van Der Heiden, Kim ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED MACROPHAGES; APOLIPOPROTEIN E; ATHEROSCLEROTIC PLAQUE; COMMON CAROTID ARTERY; FOLATE RECEPTOR; HIGH RESOLUTION; NON-INVASIVE IMAGING; VULNERABLE PLAQUES;

MACROPHAGES; MAMMALS; MOLECULAR IMAGING; PARTICLE BEAMS; TOMOGRAPHY;

DISEASES;

111IN EC0800; 111IN-EC0800; APOLIPOPROTEIN E; COORDINATION COMPOUND; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FOLATE RECEPTOR 2; FOLIC ACID; RADIOPHARMACEUTICAL AGENT;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; C57BL MOUSE; DISEASE MODEL; FEMALE; GENETICS; HUMAN; KNOCKOUT MOUSE; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; RADIATION EXPOSURE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; COORDINATION COMPLEXES; DISEASE MODELS, ANIMAL; FEMALE; FOLATE RECEPTOR 2; FOLIC ACID; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84893653419     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2013.00061     Document Type: Article

References (17)

1. Wolfs IM, Donners MM, de Winther MP. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation. Thromb Haemost 2011;106: 763-71, doi:10.1160/TH11-05- 0320.
2. Paulos CM, Turk MJ, Breur GJ, Low PS. Folate receptor-mediated targeting of therapeutic and imaging agents to activatedmacrophages in rheumatoid arthritis. Adv Drug Deliv Rev 2004;56: 1205-17, doi:10.1016/j.addr.2004.01.012.
3. Jager NA, Westra J, van Dam GM, et al. Targeted folate receptor b fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaque. J Nucl Med 2012;53: 1222-9, doi:10.2967/jnumed.111.099671.
4. Jager NA, Teteloshvili N, Zeebregts CJ, et al. Macrophage folate receptor-b (FR-b) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk? Autoimmun Rev 2012;11: 621-6, doi:10.1016/j.autrev.2011. 11.002.
5. Ayala-Lopez W, Xia W, Varghese B, Low PS. Imaging of atherosclerosis in apoliprotein E knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages. J Nucl Med 2010;51: 768-74, doi:10.2967/jnumed.109. 071324.
6. Cheng C, Tempel D, van Haperen R, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006;113: 2744-53, doi:10.1161/CIRCULATIONAHA. 105.590018.
7. Cheng C, Tempel D, van Haperen R, et al. Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Invest 2007;117: 616-26, doi:10.1172/ JCI28180.
8. Cheng C, Tempel D, van Haperen R, et al. Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype. Atherosclerosis 2009;204: 26-33, doi:10.1016/j.atherosclerosis.2009.01.025.
9. Segers D, Lipton JA, Leenen PJ, et al. Atherosclerotic plaque stability is affected by the chemokine CXCL10 in both mice and humans. Int J Inflamm 2011;2011: 936109, doi:10.4061/2011/936109.
10. van Bochove GS, Paulis LE, Segers D, et al. Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque. Contrast Media Mol Imaging 2011;6: 35-45, doi:10.1002/cmmi.402.
11. Matlung HL, Neele AE, Groen HC, et al. Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stress. Atherosclerosis 2012;224: 355-62, doi:10.1016/j.atherosclerosis. 2012.07.044.
12. Shami A, Gustafsson R, Kalamajski S, et al. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2013;33: 354-61, doi:10.1161/ATVBAHA.112.300723.
13. Müller C, Vlahov IR, Santhapuram HK, et al. Tumor targeting using 67Ga-DOTA-Bz-folate - investigations of methods to improve the tissue distribution of radiofolates. Nucl Med Biol 2011;38: 715-23, doi:10.1016/j.nucmedbio.2010.12.013.
14. Piscaer TM, Müller C, Mindt TL, et al. Imaging of activated macrophages in experimental osteoarthritis using folate targeted animal SPECT/CT. Arthritis Rheum 2011;63: 1898-907, doi:10.1002/ art.30363.
15. Müller C, Forrer F, Schibli R, et al. SPECT study of folate receptorpositive malignant and normal tissues in mice using a novel 99mTcradiofolate. J Nucl Med 2008;49: 310-7, doi:10.2967/jnumed.107. 045856.
16. Müller C, Struthers H, Winiger C, et al. DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Luradionuclide tumor therapy in mice. J Nucl Med 2013;54: 124-31, doi:10.2967/jnumed.112. 107235.
17. Müller C, Reber J, Schlup C, et al. In vitro and in vivo evaluation of an innocuous drug cocktail to improve the quality of folic acid targeted nuclear imaging in preclinical research. Mol Pharm 2013; 10:967-74, doi:10.1021/mp300428p.